|
In today’s healthcare services, it is more important than ever before to be able to demonstrate economic value. England, Scotland, Wales and Ireland – and many European countries – all have health technology assessment (HTA) bodies that assess the cost-effectiveness of a product, as well as its clinical efficacy.
HMC has an established relationship with many of the UK’s leading health economists. This means we can draw on their expertise to build economic and budget impact models, no matter what the disease area or level of complexity required.
HMC has commercial alliances with:
|
Our service goes beyond modelling for HTA submissions. You may need to produce a health economic review or publish a business case to inform pharmacists and budget holders of the impact of your product. With our long publishing history, we are ideally placed to help.
And it doesn’t stop there. We will also identify the best communication channel to deliver your message to the right audience.
To find out more about how we can help you, call 01638 723560
or email Edwina Towning or Lisa Cox
|